Robert R. Ruffolo, Director at Sigilon Therapeutics, Inc. (SGTX), sold 6,750 shares at $10.36 ($70K) on 2021-07-01, disclosed to the SEC on 2021-07-02.
Open-market sale of $70k SGTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| WYE | SELL | 2006-02-14 | $719K | — | Filing → |